nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A4—Temozolomide—melanoma	0.239	0.325	CbGbCtD
Halofantrine—CYP2D6—Vemurafenib—melanoma	0.206	0.28	CbGbCtD
Halofantrine—CYP3A4—Vemurafenib—melanoma	0.131	0.178	CbGbCtD
Halofantrine—CYP3A5—Docetaxel—melanoma	0.115	0.157	CbGbCtD
Halofantrine—CYP3A4—Docetaxel—melanoma	0.0449	0.061	CbGbCtD
Halofantrine—Rigors—Vemurafenib—melanoma	0.00935	0.0354	CcSEcCtD
Halofantrine—Altered state of consciousness—Temozolomide—melanoma	0.00845	0.032	CcSEcCtD
Halofantrine—Rigors—Temozolomide—melanoma	0.00478	0.0181	CcSEcCtD
Halofantrine—Depressed level of consciousness—Carmustine—melanoma	0.0039	0.0148	CcSEcCtD
Halofantrine—Depressed level of consciousness—Temozolomide—melanoma	0.00377	0.0143	CcSEcCtD
Halofantrine—Abnormal vision—Carmustine—melanoma	0.00352	0.0133	CcSEcCtD
Halofantrine—Chills—Vemurafenib—melanoma	0.00344	0.013	CcSEcCtD
Halofantrine—Cerebrovascular accident—Bleomycin—melanoma	0.00342	0.013	CcSEcCtD
Halofantrine—Abnormal vision—Temozolomide—melanoma	0.0034	0.0129	CcSEcCtD
Halofantrine—Back pain—Vemurafenib—melanoma	0.00323	0.0122	CcSEcCtD
Halofantrine—Rigors—Docetaxel—melanoma	0.00318	0.012	CcSEcCtD
Halofantrine—Cough—Vemurafenib—melanoma	0.00291	0.011	CcSEcCtD
Halofantrine—Myalgia—Vemurafenib—melanoma	0.00284	0.0108	CcSEcCtD
Halofantrine—Arthralgia—Vemurafenib—melanoma	0.00284	0.0108	CcSEcCtD
Halofantrine—Face oedema—Carmustine—melanoma	0.00283	0.0107	CcSEcCtD
Halofantrine—Face oedema—Temozolomide—melanoma	0.00273	0.0103	CcSEcCtD
Halofantrine—Anaphylactic shock—Vemurafenib—melanoma	0.00272	0.0103	CcSEcCtD
Halofantrine—Stomatitis—Bleomycin—melanoma	0.00252	0.00954	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00248	0.00939	CcSEcCtD
Halofantrine—Abdominal distension—Temozolomide—melanoma	0.00246	0.00933	CcSEcCtD
Halofantrine—Decreased appetite—Vemurafenib—melanoma	0.00237	0.00896	CcSEcCtD
Halofantrine—Stomatitis—Dactinomycin—melanoma	0.00235	0.0089	CcSEcCtD
Halofantrine—Fatigue—Vemurafenib—melanoma	0.00235	0.00889	CcSEcCtD
Halofantrine—Constipation—Vemurafenib—melanoma	0.00233	0.00881	CcSEcCtD
Halofantrine—Pulmonary oedema—Docetaxel—melanoma	0.00231	0.00874	CcSEcCtD
Halofantrine—Pollakiuria—Temozolomide—melanoma	0.00226	0.00856	CcSEcCtD
Halofantrine—Stomatitis—Carmustine—melanoma	0.0022	0.00833	CcSEcCtD
Halofantrine—Stomatitis—Temozolomide—melanoma	0.00213	0.00805	CcSEcCtD
Halofantrine—Chills—Bleomycin—melanoma	0.00208	0.00789	CcSEcCtD
Halofantrine—Asthenia—Vemurafenib—melanoma	0.00195	0.0074	CcSEcCtD
Halofantrine—Visual impairment—Carmustine—melanoma	0.00195	0.00739	CcSEcCtD
Halofantrine—Chills—Dactinomycin—melanoma	0.00194	0.00736	CcSEcCtD
Halofantrine—Pruritus—Vemurafenib—melanoma	0.00193	0.00729	CcSEcCtD
Halofantrine—Visual impairment—Temozolomide—melanoma	0.00189	0.00715	CcSEcCtD
Halofantrine—Ill-defined disorder—Bleomycin—melanoma	0.00188	0.0071	CcSEcCtD
Halofantrine—Diarrhoea—Vemurafenib—melanoma	0.00186	0.00705	CcSEcCtD
Halofantrine—Tinnitus—Temozolomide—melanoma	0.00183	0.00691	CcSEcCtD
Halofantrine—Malaise—Bleomycin—melanoma	0.00182	0.0069	CcSEcCtD
Halofantrine—Arrhythmia—Carmustine—melanoma	0.00181	0.00685	CcSEcCtD
Halofantrine—Dizziness—Vemurafenib—melanoma	0.0018	0.00682	CcSEcCtD
Halofantrine—Cough—Bleomycin—melanoma	0.00176	0.00668	CcSEcCtD
Halofantrine—Chills—Temozolomide—melanoma	0.00176	0.00665	CcSEcCtD
Halofantrine—Ill-defined disorder—Dactinomycin—melanoma	0.00175	0.00662	CcSEcCtD
Halofantrine—Vomiting—Vemurafenib—melanoma	0.00173	0.00655	CcSEcCtD
Halofantrine—Myalgia—Bleomycin—melanoma	0.00172	0.00651	CcSEcCtD
Halofantrine—Chest pain—Bleomycin—melanoma	0.00172	0.00651	CcSEcCtD
Halofantrine—Orthostatic hypotension—Docetaxel—melanoma	0.00172	0.00651	CcSEcCtD
Halofantrine—Rash—Vemurafenib—melanoma	0.00172	0.0065	CcSEcCtD
Halofantrine—Dermatitis—Vemurafenib—melanoma	0.00171	0.00649	CcSEcCtD
Halofantrine—Back pain—Carmustine—melanoma	0.00171	0.00646	CcSEcCtD
Halofantrine—Headache—Vemurafenib—melanoma	0.00171	0.00646	CcSEcCtD
Halofantrine—Discomfort—Bleomycin—melanoma	0.0017	0.00644	CcSEcCtD
Halofantrine—Malaise—Dactinomycin—melanoma	0.0017	0.00644	CcSEcCtD
Halofantrine—Confusional state—Bleomycin—melanoma	0.00166	0.0063	CcSEcCtD
Halofantrine—Anaphylactic shock—Bleomycin—melanoma	0.00165	0.00624	CcSEcCtD
Halofantrine—Back pain—Temozolomide—melanoma	0.00165	0.00624	CcSEcCtD
Halofantrine—Nausea—Vemurafenib—melanoma	0.00162	0.00612	CcSEcCtD
Halofantrine—Myalgia—Dactinomycin—melanoma	0.0016	0.00608	CcSEcCtD
Halofantrine—Discomfort—Dactinomycin—melanoma	0.00159	0.006	CcSEcCtD
Halofantrine—Ill-defined disorder—Temozolomide—melanoma	0.00158	0.00599	CcSEcCtD
Halofantrine—Anorexia—Bleomycin—melanoma	0.00157	0.00595	CcSEcCtD
Halofantrine—Malaise—Temozolomide—melanoma	0.00154	0.00582	CcSEcCtD
Halofantrine—Convulsion—Carmustine—melanoma	0.00153	0.00579	CcSEcCtD
Halofantrine—Palpitations—Temozolomide—melanoma	0.00151	0.0057	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Bleomycin—melanoma	0.0015	0.00569	CcSEcCtD
Halofantrine—Chest pain—Carmustine—melanoma	0.0015	0.00569	CcSEcCtD
Halofantrine—Myalgia—Carmustine—melanoma	0.0015	0.00569	CcSEcCtD
Halofantrine—Cough—Temozolomide—melanoma	0.00149	0.00563	CcSEcCtD
Halofantrine—Paraesthesia—Bleomycin—melanoma	0.00148	0.00561	CcSEcCtD
Halofantrine—Convulsion—Temozolomide—melanoma	0.00148	0.00559	CcSEcCtD
Halofantrine—Anorexia—Dactinomycin—melanoma	0.00147	0.00555	CcSEcCtD
Halofantrine—Confusional state—Carmustine—melanoma	0.00145	0.0055	CcSEcCtD
Halofantrine—Arthralgia—Temozolomide—melanoma	0.00145	0.0055	CcSEcCtD
Halofantrine—Myalgia—Temozolomide—melanoma	0.00145	0.0055	CcSEcCtD
Halofantrine—Discomfort—Temozolomide—melanoma	0.00143	0.00543	CcSEcCtD
Halofantrine—Decreased appetite—Bleomycin—melanoma	0.00143	0.00543	CcSEcCtD
Halofantrine—Stomatitis—Docetaxel—melanoma	0.00141	0.00535	CcSEcCtD
Halofantrine—Confusional state—Temozolomide—melanoma	0.0014	0.00531	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.0014	0.00531	CcSEcCtD
Halofantrine—Anaphylactic shock—Temozolomide—melanoma	0.00139	0.00527	CcSEcCtD
Halofantrine—Anorexia—Carmustine—melanoma	0.00137	0.0052	CcSEcCtD
Halofantrine—Feeling abnormal—Bleomycin—melanoma	0.00136	0.00515	CcSEcCtD
Halofantrine—Decreased appetite—Dactinomycin—melanoma	0.00134	0.00506	CcSEcCtD
Halofantrine—Fatigue—Dactinomycin—melanoma	0.00133	0.00502	CcSEcCtD
Halofantrine—Anorexia—Temozolomide—melanoma	0.00133	0.00502	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Carmustine—melanoma	0.00131	0.00497	CcSEcCtD
Halofantrine—Urticaria—Bleomycin—melanoma	0.00131	0.00496	CcSEcCtD
Halofantrine—Paraesthesia—Carmustine—melanoma	0.00129	0.00489	CcSEcCtD
Halofantrine—Feeling abnormal—Dactinomycin—melanoma	0.00127	0.0048	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00127	0.0048	CcSEcCtD
Halofantrine—Gastrointestinal pain—Dactinomycin—melanoma	0.00126	0.00476	CcSEcCtD
Halofantrine—Visual impairment—Docetaxel—melanoma	0.00125	0.00475	CcSEcCtD
Halofantrine—Decreased appetite—Carmustine—melanoma	0.00125	0.00474	CcSEcCtD
Halofantrine—Paraesthesia—Temozolomide—melanoma	0.00125	0.00473	CcSEcCtD
Halofantrine—Constipation—Carmustine—melanoma	0.00123	0.00466	CcSEcCtD
Halofantrine—Dyspepsia—Temozolomide—melanoma	0.00122	0.00464	CcSEcCtD
Halofantrine—Abdominal pain—Dactinomycin—melanoma	0.00122	0.0046	CcSEcCtD
Halofantrine—Decreased appetite—Temozolomide—melanoma	0.00121	0.00458	CcSEcCtD
Halofantrine—Fatigue—Temozolomide—melanoma	0.0012	0.00454	CcSEcCtD
Halofantrine—Constipation—Temozolomide—melanoma	0.00119	0.0045	CcSEcCtD
Halofantrine—Feeling abnormal—Carmustine—melanoma	0.00119	0.00449	CcSEcCtD
Halofantrine—Asthenia—Bleomycin—melanoma	0.00118	0.00448	CcSEcCtD
Halofantrine—Gastrointestinal pain—Carmustine—melanoma	0.00118	0.00446	CcSEcCtD
Halofantrine—Chills—Docetaxel—melanoma	0.00117	0.00442	CcSEcCtD
Halofantrine—Pruritus—Bleomycin—melanoma	0.00117	0.00442	CcSEcCtD
Halofantrine—Arrhythmia—Docetaxel—melanoma	0.00116	0.0044	CcSEcCtD
Halofantrine—Feeling abnormal—Temozolomide—melanoma	0.00115	0.00434	CcSEcCtD
Halofantrine—Abdominal pain—Carmustine—melanoma	0.00114	0.00431	CcSEcCtD
Halofantrine—Gastrointestinal pain—Temozolomide—melanoma	0.00114	0.00431	CcSEcCtD
Halofantrine—Urticaria—Temozolomide—melanoma	0.00111	0.00418	CcSEcCtD
Halofantrine—Asthenia—Dactinomycin—melanoma	0.0011	0.00418	CcSEcCtD
Halofantrine—Abdominal pain—Temozolomide—melanoma	0.0011	0.00416	CcSEcCtD
Halofantrine—Back pain—Docetaxel—melanoma	0.0011	0.00415	CcSEcCtD
Halofantrine—Diarrhoea—Dactinomycin—melanoma	0.00105	0.00399	CcSEcCtD
Halofantrine—Vomiting—Bleomycin—melanoma	0.00105	0.00397	CcSEcCtD
Halofantrine—Rash—Bleomycin—melanoma	0.00104	0.00394	CcSEcCtD
Halofantrine—Dermatitis—Bleomycin—melanoma	0.00104	0.00393	CcSEcCtD
Halofantrine—Asthenia—Carmustine—melanoma	0.00103	0.00391	CcSEcCtD
Halofantrine—Palpitations—Docetaxel—melanoma	0.001	0.00379	CcSEcCtD
Halofantrine—Asthenia—Temozolomide—melanoma	0.000998	0.00378	CcSEcCtD
Halofantrine—Cough—Docetaxel—melanoma	0.000989	0.00375	CcSEcCtD
Halofantrine—Diarrhoea—Carmustine—melanoma	0.000985	0.00373	CcSEcCtD
Halofantrine—Pruritus—Temozolomide—melanoma	0.000984	0.00373	CcSEcCtD
Halofantrine—Convulsion—Docetaxel—melanoma	0.000982	0.00372	CcSEcCtD
Halofantrine—Nausea—Bleomycin—melanoma	0.00098	0.00371	CcSEcCtD
Halofantrine—Vomiting—Dactinomycin—melanoma	0.000978	0.0037	CcSEcCtD
Halofantrine—Rash—Dactinomycin—melanoma	0.00097	0.00367	CcSEcCtD
Halofantrine—Arthralgia—Docetaxel—melanoma	0.000965	0.00365	CcSEcCtD
Halofantrine—Chest pain—Docetaxel—melanoma	0.000965	0.00365	CcSEcCtD
Halofantrine—Myalgia—Docetaxel—melanoma	0.000965	0.00365	CcSEcCtD
Halofantrine—Dizziness—Carmustine—melanoma	0.000952	0.0036	CcSEcCtD
Halofantrine—Diarrhoea—Temozolomide—melanoma	0.000952	0.0036	CcSEcCtD
Halofantrine—Confusional state—Docetaxel—melanoma	0.000933	0.00353	CcSEcCtD
Halofantrine—Anaphylactic shock—Docetaxel—melanoma	0.000925	0.0035	CcSEcCtD
Halofantrine—Dizziness—Temozolomide—melanoma	0.00092	0.00348	CcSEcCtD
Halofantrine—Vomiting—Carmustine—melanoma	0.000915	0.00347	CcSEcCtD
Halofantrine—Nausea—Dactinomycin—melanoma	0.000914	0.00346	CcSEcCtD
Halofantrine—Rash—Carmustine—melanoma	0.000908	0.00344	CcSEcCtD
Halofantrine—Dermatitis—Carmustine—melanoma	0.000907	0.00343	CcSEcCtD
Halofantrine—Headache—Carmustine—melanoma	0.000902	0.00341	CcSEcCtD
Halofantrine—Vomiting—Temozolomide—melanoma	0.000885	0.00335	CcSEcCtD
Halofantrine—Anorexia—Docetaxel—melanoma	0.000882	0.00334	CcSEcCtD
Halofantrine—Rash—Temozolomide—melanoma	0.000877	0.00332	CcSEcCtD
Halofantrine—Dermatitis—Temozolomide—melanoma	0.000876	0.00332	CcSEcCtD
Halofantrine—Headache—Temozolomide—melanoma	0.000872	0.0033	CcSEcCtD
Halofantrine—Nausea—Carmustine—melanoma	0.000855	0.00324	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000843	0.00319	CcSEcCtD
Halofantrine—Paraesthesia—Docetaxel—melanoma	0.000831	0.00315	CcSEcCtD
Halofantrine—Nausea—Temozolomide—melanoma	0.000826	0.00313	CcSEcCtD
Halofantrine—Dyspepsia—Docetaxel—melanoma	0.000814	0.00308	CcSEcCtD
Halofantrine—Decreased appetite—Docetaxel—melanoma	0.000804	0.00305	CcSEcCtD
Halofantrine—Fatigue—Docetaxel—melanoma	0.000798	0.00302	CcSEcCtD
Halofantrine—Constipation—Docetaxel—melanoma	0.000791	0.003	CcSEcCtD
Halofantrine—Feeling abnormal—Docetaxel—melanoma	0.000762	0.00289	CcSEcCtD
Halofantrine—Gastrointestinal pain—Docetaxel—melanoma	0.000757	0.00286	CcSEcCtD
Halofantrine—Abdominal pain—Docetaxel—melanoma	0.000731	0.00277	CcSEcCtD
Halofantrine—Asthenia—Docetaxel—melanoma	0.000664	0.00251	CcSEcCtD
Halofantrine—Pruritus—Docetaxel—melanoma	0.000655	0.00248	CcSEcCtD
Halofantrine—Diarrhoea—Docetaxel—melanoma	0.000633	0.0024	CcSEcCtD
Halofantrine—Dizziness—Docetaxel—melanoma	0.000612	0.00232	CcSEcCtD
Halofantrine—Vomiting—Docetaxel—melanoma	0.000588	0.00223	CcSEcCtD
Halofantrine—Rash—Docetaxel—melanoma	0.000583	0.00221	CcSEcCtD
Halofantrine—Dermatitis—Docetaxel—melanoma	0.000583	0.00221	CcSEcCtD
Halofantrine—Headache—Docetaxel—melanoma	0.00058	0.00219	CcSEcCtD
Halofantrine—Nausea—Docetaxel—melanoma	0.00055	0.00208	CcSEcCtD
